BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21178660)

  • 1. Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion.
    Sodi A; Giambene B; Marcucci R; Sofi F; Fedi S; Abbate R; Prisco D; Menchini U
    Retina; 2011 Apr; 31(4):724-9. PubMed ID: 21178660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion.
    Sodi A; Giambene B; Marcucci R; Sofi F; Bolli P; Abbate R; Prisco D; Menchini U
    Eur J Ophthalmol; 2008; 18(2):233-8. PubMed ID: 18320516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia, a biochemical tool for differentiating ischemic and nonischemic central retinal vein occlusion during the early acute phase.
    Lahiri KD; Mukherjee S; Ghosh S; Mukherjee S; Dutta J; Datta H; Das HN
    Korean J Ophthalmol; 2015 Apr; 29(2):86-91. PubMed ID: 25829824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.
    Dong N; Xu B; Tang X
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4057-62. PubMed ID: 24906854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion.
    Lattanzio R; Sampietro F; Ramoni A; Fattorini A; Brancato R; D'Angelo A
    Retina; 2006 Jan; 26(1):65-70. PubMed ID: 16395141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilic and cardiovascular risk factors for retinal vein occlusion.
    Bucciarelli P; Passamonti SM; Gianniello F; Artoni A; Martinelli I
    Eur J Intern Med; 2017 Oct; 44():44-48. PubMed ID: 28684050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine in patients with retinal vein occlusion.
    Minniti G; Calevo MG; Giannattasio A; Camicione P; Armani U; Lorini R; Piana G
    Eur J Ophthalmol; 2014; 24(5):735-43. PubMed ID: 24519513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population.
    Narayanasamy A; Subramaniam B; Karunakaran C; Ranganathan P; Sivaramakrishnan R; Sharma T; Badrinath VS; Roy J
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1441-6. PubMed ID: 17389469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia and central retinal vein occlusion in Iranian population.
    Moghimi S; Najmi Z; Faghihi H; Karkhaneh R; Farahvash MS; Maghsoudipour M
    Int Ophthalmol; 2008 Feb; 28(1):23-8. PubMed ID: 17636432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.
    Janssen MC; den Heijer M; Cruysberg JR; Wollersheim H; Bredie SJ
    Thromb Haemost; 2005 Jun; 93(6):1021-6. PubMed ID: 15968383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.
    Gao W; Wang YS; Zhang P; Wang HY
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1246-9. PubMed ID: 16538453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.
    Vine AK
    Trans Am Ophthalmol Soc; 2000; 98():493-503. PubMed ID: 11190038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE.
    Liu Q; Lahey JM; Karlen R; Stewart JM
    Retina; 2018 Jun; 38(6):1175-1179. PubMed ID: 28613222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion?
    Gumus K; Kadayifcilar S; Eldem B; Saracbasi O; Ozcebe O; Dundar S; Kirazli S
    Clin Exp Ophthalmol; 2006; 34(4):305-11. PubMed ID: 16764648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central retinal vein occlusion and thrombophilia.
    Fegan CD
    Eye (Lond); 2002 Jan; 16(1):98-106. PubMed ID: 11913903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilic risk factors in patients with central retinal vein occlusion.
    Marcucci R; Bertini L; Giusti B; Brunelli T; Fedi S; Cellai AP; Poli D; Pepe G; Abbate R; Prisco D
    Thromb Haemost; 2001 Sep; 86(3):772-6. PubMed ID: 11583306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of rheologic factors in patients with acute central retinal vein occlusion.
    Arend O; Remky A; Jung F; Kiesewetter H; Reim M; Wolf S
    Ophthalmology; 1996 Jan; 103(1):80-6. PubMed ID: 8628564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of risk factors for retinal vein occlusions in patients under 60 years of age].
    Salaun N; Delyfer MN; Rougier MB; Korobelnik JF
    J Fr Ophtalmol; 2007 Nov; 30(9):918-23. PubMed ID: 18046276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion.
    Vine AK
    Am J Ophthalmol; 2000 May; 129(5):640-4. PubMed ID: 10844057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.